Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status (Q38170591)

30 August 2017

Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status (English)

1 reference

World Health Organization

30 August 2017

0 references

1 reference

Karen Hennessey

1

1 reference

30 August 2017

Jorge Mendoza-Aldana

2

1 reference

30 August 2017

Benjamin Bayutas

3

1 reference

30 August 2017

Kayla Mae Lorenzo-Mariano

4

1 reference

30 August 2017

Sergey Diorditsa

5

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

31 Suppl 9

1 reference

30 August 2017

J85-92

1 reference

Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Progress in the control of hepatitis B infection in the Western Pacific Region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Epidemiology of hepatitis B infection in the Western Pacific and South East Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Natural history of chronic hepatitis B in Euro-Mediterranean and African countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Long-term outcome in children with chronic hepatitis B: a 24-year observation period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

The global health burden of infection-associated cancers in the year 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Mongolia's struggle with liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

WHO and UNICEF estimates of national infant immunization coverage: methods and processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Improved immunization practices reduce childhood hepatitis B infection in Tonga.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Immediate newborn care practices delay thermoregulation and breastfeeding initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

4 million neonatal deaths: when? Where? Why?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.10.082

10.1016/J.VACCINE.2012.10.082

7 January 2021

Identifiers

DOI

1 reference

30 August 2017

1 reference